Patents by Inventor Rachel Alison Fallon

Rachel Alison Fallon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR LUPUS
    Publication number: 20110207613
    Abstract: The present invention provides biomarkers valuable in diagnosing or detecting a susceptibility to lupus. The present invention also provides panels of biomarkers valuable in diagnosing or detecting a susceptibility to lupus with good specificity and selectivity. Said biomarkers and panels of biomarkers are also useful in monitoring the progression or regression of lupus, or monitoring the progression to a flare of the disease or transition from a flare into remission or monitoring the efficacy of a therapeutic agent to lupus.
    Type: Application
    Filed: June 11, 2009
    Publication date: August 25, 2011
    Inventors: Martin Johannes Ebner, Colin Henry Wheeler, Rachel Alison Fallon, Sarah Paula Joyce, Jens-Oliver Koopman, Michael Bernard McAndrew, Nicholas Ian Workman
  • Relating to assay systems
    Patent number: 6074829
    Abstract: A method for detecting an interaction between two proteins while eliminating false positive interactions, the method being particularly useful for application in the two-hybrid system and for the screening of libraries of unknown proteins. In a two-hybrid system employing the method, two different repoter genes having different promoters and two different DNA-binding domains which specifically bind to those promoters, are used.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: June 13, 2000
    Assignee: Amersham International PLC
    Inventors: Douglas Hurd, Rachel Alison Fallon, Michael White, Nicholas Jones
  • Reverse two-hybrid system employing post-translation signal modulation
    Patent number: 5948620
    Abstract: The invention relates to modified two-hybrid systems, in particular a reverse two-hybrid system which employs as a reporter a gene encoding a modifying agent such as an enzyme, and a signal agent which is modified by the enzyme usually by being broken down, such that in the event of an inhibition of binding of the two hybrid proteins a detectable signal is produced. The system is particularly useful for drug screening.
    Type: Grant
    Filed: August 4, 1997
    Date of Patent: September 7, 1999
    Assignee: Amersham International PLC
    Inventors: Douglas Hurd, Rachel Alison Fallon, Nicholas Ian Workman, Susan Jane Dale